To the Editor We read with great interest the analysis of a cohort of breast cancer survivors with alopecia by Bhoyrul et al.1 Determining adverse events to treatments is key in oncodermatology, such that the grading system used in oncology studies (the Common Terminology Criteria for Adverse Events)2 has 5 categories: definite, probable, possible, unlikely, or unrelated. The importance of proper causation lies in the notion that multimodal (ie, systemic therapy, radiation) and polypharmacy (multiple systemic agents) are common in cancer treatments.
Freites-Martinez A, Shapiro J. Diagnosis of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors. JAMA Dermatol. 2022;158(6):704. doi:10.1001/jamadermatol.2022.1113
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.